Skip to main content

Elias Uhlin

Research description

Developing human induced Pluripotent stem (hiPS) cell-derived therapies.

Current projects

  • Deriving clinically relevant hiPS cells under cGMP compliant conditions
  • Investigating human neuroepithelial stem (hNES) cell therapy in preclinical spinal cord injury models
  • Establishing a HLA-matched hiPS cells bank of Clinically relevant hiPS cells




Loading bibliometrics...